Seres Therapeutics, Inc.

NASDAQ:MCRB

0.8074 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q4
Revenue 000.0640.31126.473-0.5220.9753.4441.2161.4937.221126.7255.2635.71817.5641.4176.0458.1897.6227.03112.5317.32110.6299.0554.6123.9713.05623.0153.0143.0153.03613.0153.0042.71000000000
Cost of Revenue 1.421.5594.0530.5192.1063.6071.00443.11643.9350.97636.7521.12735.95429.30324.86723.86120.09921.74321.03218.31717.90522.88724.76723.67524.05323.4624.04222.2123.0620.14320.25624.14322.17415.41613.99.858.7845.56100000
Gross Profit -1.42-1.559-3.989-0.209124.367-4.129-0.029-39.672-42.7190.517-29.531125.598-30.691-23.585-7.303-22.444-14.054-13.554-13.41-11.286-5.374-15.566-14.138-14.62-19.441-19.489-20.9860.805-20.046-17.128-17.22-11.128-19.17-12.706-13.9-9.85-8.784-5.56100000
Gross Profit Ratio 00-62.328-0.6740.9837.91-0.03-11.519-35.1310.346-4.090.991-5.831-4.125-0.416-15.839-2.325-1.655-1.759-1.605-0.429-2.126-1.33-1.615-4.215-4.908-6.8670.035-6.651-5.681-5.672-0.855-6.381-4.689000000000
Reseach & Development Expenses 17.87521.70226.84628.25346.79243.96946.2243.11643.93539.64936.75239.88235.95429.30324.86723.86120.09921.74321.03218.31717.90522.88724.76723.67524.05323.4624.04222.2123.0620.14320.25624.14322.17415.41613.99.858.7845.5615.062.4662.161.0321.517
General & Administrative Expenses 16.05915.46617.23419.98928.05122.4722.40418.38420.33518.57120.50619.56317.45111.74110.5957.5516.4916.1385.7825.8975.5747.4957.5337.5918.6958.7778.7898.1198.378.7628.4537.9678.977.215.8884.7113.5562.6062.1531.1130.4580.640.388
Selling & Marketing Expenses -1.42-1.559-4.0530000000000000000000000000000000000000000
SG&A 14.63913.90713.18119.98928.05122.4722.40418.38420.33518.57120.50619.56317.45111.74110.5957.5516.4916.1385.7825.8975.5747.4957.5337.5918.6958.7778.7898.1198.378.7628.4537.9678.977.215.8884.7113.5562.6062.1531.1130.4580.640.388
Other Expenses 0.6922.4680.3360.999-1.5113.6070.658-0.033-0.304-0.976-0.316-0.035-0.285-0.409-0.2080.3450.4760.3680.6270.43901.49200001.124-0.123-0.217-0.3590000000000000
Operating Expenses 32.51435.60940.02747.72376.94970.04669.28262.55164.54157.24456.65358.31853.40541.04435.46231.41226.5927.88126.81424.21423.47930.38232.331.26632.74832.23732.83130.32931.4328.90528.70932.1131.14422.62619.78814.56112.348.1677.2133.5792.6181.6721.913
Operating Income -33.934-37.168-44.016-47.41349.524-70.568-68.307-59.107-63.325-55.751-49.43268.407-48.142-35.326-17.898-29.995-20.545-19.692-19.192-17.183-10.948-24.553-21.671-22.211-28.136-28.266-29.775-7.314-28.416-25.89-25.673-19.095-28.14-19.916-19.788-14.561-12.34-8.167-7.213-3.579-2.618-1.672-1.905
Operating Income Ratio 00-687.75-152.9450.392135.188-70.058-17.162-52.076-37.342-6.8460.54-9.147-6.178-1.019-21.168-3.399-2.405-2.518-2.444-0.874-3.354-2.039-2.453-6.101-7.118-9.743-0.318-9.428-8.587-8.456-1.467-9.368-7.349000000000
Total Other Income Expenses Net 1.064-2.9652.7680.999-1.511-0.606-0.489-0.033-0.304-0.873-0.316-0.035-0.285-0.409-0.2080.3450.4760.3680.6270.4390.189-1.4920.3840.2620.3490.3471.124-0.123-0.217-0.3590.3970.4070.2270.2120.154-0.059-0.220.213-0.914-0.521-0.0030.02-0.044
Income Before Tax -32.87-40.133-41.248-47.85446.552-71.174-68.796-60.002-64.735-56.624-50.00168.218-48.33-35.465-18.252-30.28-20.714-19.881-18.778-16.409-10.759-24.333-21.287-21.949-27.787-27.919-28.953-6.935-28.018-25.474-25.276-18.688-27.913-19.704-19.634-14.62-12.555-7.971-8.182-4.161-2.677-1.689-1.949
Income Before Tax Ratio 00-644.5-154.3680.368136.349-70.56-17.422-53.236-37.926-6.9240.538-9.183-6.202-1.039-21.369-3.427-2.428-2.464-2.334-0.859-3.324-2.003-2.424-6.025-7.031-9.474-0.301-9.296-8.449-8.325-1.436-9.292-7.271000000000
Income Tax Expense -01.516-2.1951.440.1490.6060.4891.6941.1970.873-5.0820.7090.4470.2870.5511.0751.1951.084-0.98-0.33501.27200000.302-0.502-0.615-2.5050.7460.7190.4950.2680.631-0.1820.095-0.1960.9690.5820.0590.0170.221
Net Income -32.87-40.133-41.248-47.85446.552-71.78-69.285-60.002-64.735-57.497-50.00168.218-48.33-35.465-18.252-30.28-20.714-19.881-18.778-16.409-10.759-24.333-21.287-21.949-27.787-27.919-28.953-6.935-28.018-25.474-25.276-18.688-27.913-19.704-19.634-14.62-12.555-7.971-8.182-4.161-2.677-1.689-2.17
Net Income Ratio 00-644.5-154.3680.368137.51-71.062-17.422-53.236-38.511-6.9240.538-9.183-6.202-1.039-21.369-3.427-2.428-2.464-2.334-0.859-3.324-2.003-2.424-6.025-7.031-9.474-0.301-9.296-8.449-8.325-1.436-9.292-7.271000000000
EPS -0.22-0.27-0.32-0.370.36-0.57-0.55-0.49-0.7-0.62-0.540.74-0.53-0.39-0.22-0.36-0.28-0.28-0.27-0.23-0.24-0.59-0.52-0.54-0.68-0.69-0.71-0.17-0.69-0.63-0.63-0.46-0.7-0.5-0.5-0.38-1.45-0.22-0.27-0.14-0.09-0.057-0.33
EPS Diluted -0.22-0.27-0.32-0.370.36-0.57-0.55-0.49-0.7-0.62-0.530.72-0.53-0.39-0.22-0.36-0.28-0.28-0.27-0.23-0.24-0.59-0.52-0.54-0.68-0.69-0.71-0.17-0.69-0.63-0.63-0.46-0.7-0.5-0.5-0.38-1.45-0.22-0.27-0.14-0.09-0.057-0.33
EBITDA -32.514-35.609-39.963-43.84249.739-67.826-65.289-56.528-61.549-54.142-47.71170.455-46.172-33.293-15.984-27.974-18.304-17.363-18.585-15.307-9.562-19.028-19.678-20.237-26.182-26.325-27.872-5.448-26.656-25.89-23.233-17.125-26.771-19.262-18.823-14.561-12.12-8.288-6.222-3.011-2.579-1.662-1.879
EBITDA Ratio 00-624.422-141.4260.393129.935-66.963-16.413-50.616-36.264-6.6070.556-8.773-5.822-0.91-19.742-3.028-2.12-2.438-2.177-0.763-2.599-1.851-2.235-5.677-6.629-9.12-0.237-8.844-8.587-7.653-1.316-8.912-7.108000000000